Lundbeck wants Merck EVP as board member

Following Vestas CEO Henrik Andersen's decision to leave Lundbeck's board the pharmaceutical firm has found his replacement at German company Merck.
Merck EVP Dorothea Wenzel | Photo: Merck KGaA / PR
Merck EVP Dorothea Wenzel | Photo: Merck KGaA / PR
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN

Lundbeck nominates Dorothea Wenzel to replace Henrik Andersen on the board, since he will not be running again.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading